Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The role of melatonin in the pathogenesis of multiple sclerosis: a case-control study.
Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI.
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors.
Natalizumab: A Review of Its Use in the Management of Relapsing-Remitting Multiple Sclerosis.
Evidence of aquaporin involvement in human central pontine myelinolysis.
Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?
Acute-onset multifocal motor neuropathy (AMMN):how we meet the diagnosis.
Immunosenescence of microglia and macrophages: impact on the ageing central nervous system.
Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome.
Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosis.
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases.
Variants of MicroRNA Genes: Gender-Specific Associations with Multiple Sclerosis Risk and Severity.
[Microglia in neuroimmunological disorders].
Robotic gait rehabilitation and substitution devices in neurological disorders: where are we now?
iNKT-cells and their ligands: focus on multiple sclerosis.
Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation.
The role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differences.
Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.
The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results.
Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).
Employment and multiple sclerosis in new zealand.
PERK Activation Preserves the Viability and Function of Remyelinating Oligodendrocytes in Immune-Mediated Demyelinating Diseases.
Gender differences in caregiver strain, needs for support, social support, and quality of life among spousal caregivers of persons with multiple sclerosis.
[Demyelinating diseases in children with acute neurological symptoms].
Pages
« first
‹ previous
…
612
613
614
615
616
617
618
619
620
…
next ›
last »